Ceftazidime as first-line therapy for fever in acute leukaemia |
| |
Authors: | JP Donnelly RE Marcus JM Goldman J Cohen AM Worsley D Catovsky JH Darrell SV Want DAG Galton |
| |
Institution: | Medical Research Council Leukaemia Unit and the Department of Bacteriology, Royal Postgraduate Medical School, Ducane Road, London W12 oHS, UK |
| |
Abstract: | Fifty patients with acute non-lymphocytic leukaemia were treated by random allocation with either ceftazidime alone or a combination of piperacillin, netilmicin and cefotaxime for 65 febrile neutropenic episodes. Nineteen of 33 patient episodes (58%) responded to ceftazidime alone compared with 21 of 32 episodes (66%) treated with the combination. There was one infective death in a patient given the combination; rates of documented superinfection were low. The treatment groups appeared identical in terms of patient demography, underlying disease and other risk factors, though patients with a clinical site of infection responded more slowly than those without. Bacteraemia per se did not appear to influence outcome. Bactericidal serum concentrations greater than or equal to 8 X the minimum bactericidal concentration were predictive of a rapid response (within 4 days) to antibiotics. Furthermore, serum from patients treated with ceftazidime maintained adequate cidal activity against Pseudomonas aeruginosa for longer than that obtained from patients treated with the three-drug combination. Ceftazidime was shown to be a safe and effective alternative to the three-drug combination for the initial management of febrile neutropenic episodes in leukaemic patients. |
| |
Keywords: | Correspondence should be addressed to J P Donnelly Department of Bacteriology Royal Postgraduate Medical School Ducane Road London Wit oHS |
本文献已被 ScienceDirect 等数据库收录! |